| Phase i / bioequivalence |
| |
|
Our GCP-compliant
custom built 360 bed Phase I clinical unit is at the core of our operations. This
115,000 square foot facility is divided into 6
fully-independent clinics. The facility is also
self-sustaining, including onsite kitchen, bi-fuel back-up generator
for complete clinical operations, and UPS system.
Designed to optimize operational efficiency and provide
a comfortable environment for the study participants -
we have the ideal infrastructure for clinical research
studies.
Combined with
our team of medical professionals, extensive SOPs, well
developing training programs, and innovative
technological systems - PMRI has all the tools to offer
you world class services.
We have completed over 1500 studies
for submission to regulatory agencies around the world
and have extensive experience with various dosage forms including:
|
Solid oral
Injectables
Oral suspensions
Solutions
|
Transdermal patches
Creams
Eye drops
Nasal sprays |
We are also fully licensed for the to run studies with controlled substances. |
 |
|
Special Populations & BE Patient Studies
We recognize that dosing a short panel can have a
dramatic impact on the success of your study.
We are proud to let you know that 98% of studies dosed a full panel in 2007.
Successful subject recruitment and promoting subject
compliance (ambulatory blood draws, etc) are top
priorities at Pharma Medica.
Through our extensive recruiting and screening database and network of hospital-based partners,
we are able to run studies in a variety of special population healthy volunteers and patients:
|